Home›Companies›Healthcare›myBiometry

Biometry Inc.

Develops breath monitoring technology for people with asthma and COPD.

Updated Nov 10, 2026·Latest SEC filing Jul 23, 2026·Suggest an edit

About myBiometry

myBiometry is a private company based in Lowell, Massachusetts. It has reported $8,572,174 raised in two offerings on Form D since August 2024. Its chief executive is Bryan Nolan.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 5, 2025Dec 19, 2025amended Jul 23, 2026$3,585,772of $4.9M target67$53,519EquityRule 506(b)Form D/A ↗1 earlier filing
Aug 16, 2024Aug 30, 2024$4,986,402of $4.9M target59$84,515EquityRule 506(b)Form D ↗
Total, two offerings$8,572,174

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on myBiometry's Form D filed Jul 23, 2026.

Earlier filings also listed Anmol Wassan (executive officer, last listed Aug 2024).

Sources

  1. SECBiometry Inc. Form D, filed Dec 19, 2025
  2. SECBiometry Inc. filing history
  3. CompanyContact
  4. CompanyTeam
  5. CompanySeed funding announcement